2012
DOI: 10.1074/jbc.m112.358523
|View full text |Cite
|
Sign up to set email alerts
|

Chemoenzymatic Synthesis of Heparin Oligosaccharides with both Anti-factor Xa and Anti-factor IIa Activities

Abstract: Background: Heparin inhibits the activity of factors Xa and IIa in the blood coagulation cascade. Results: A series of size-defined N-sulfated oligosaccharides were synthesized to probe the size requirement for the oligosaccharides displaying anti-IIa activity. Conclusion: Oligosaccharides that display anti-IIa activity are longer than 19 saccharide residues. Significance: The results will direct efforts to prepare synthetic heparin with both anti-Xa and anti-IIa activities.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
56
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
3

Relationship

4
6

Authors

Journals

citations
Cited by 53 publications
(57 citation statements)
references
References 31 publications
1
56
0
Order By: Relevance
“…New “top-down” analytical methods based on tandem mass spectrometry and ion-mobility methods hold great promise for providing much greater contextual information about the structures of 3- O -sulfation sites (Kailemia et al, 2013; Meissen et al, 2009). Chemical and chemoenzymatic methods have been recently developed that have the capacity to produce multimilligram quantities of defined oligosaccharides, providing much needed reagents to aid in the discovery of new ligands and to characterize the binding sites in the enzymes and in the protein ligands (Arungundram et al, 2009; Xu et al, 2011; Xu et al, 2012). Genetic studies of model organisms focused on 3- O -sulfation have begun to yield interesting insights into the biological function of the Hs3sts and new ligands to study.…”
Section: Discussionmentioning
confidence: 99%
“…New “top-down” analytical methods based on tandem mass spectrometry and ion-mobility methods hold great promise for providing much greater contextual information about the structures of 3- O -sulfation sites (Kailemia et al, 2013; Meissen et al, 2009). Chemical and chemoenzymatic methods have been recently developed that have the capacity to produce multimilligram quantities of defined oligosaccharides, providing much needed reagents to aid in the discovery of new ligands and to characterize the binding sites in the enzymes and in the protein ligands (Arungundram et al, 2009; Xu et al, 2011; Xu et al, 2012). Genetic studies of model organisms focused on 3- O -sulfation have begun to yield interesting insights into the biological function of the Hs3sts and new ligands to study.…”
Section: Discussionmentioning
confidence: 99%
“…The expression of these enzymes were carried out in Escherichia coli and purified by an amylose-agarose column (New England Biolabs) as previously described (53).…”
Section: Methodsmentioning
confidence: 99%
“…The following enzymes and appropriate expression vectors and bacterial expression cells, prepared as previously described [26]. These enzymes include rat AST-IV (EC 2.8.2.1) in pET15 expression vector and BL21 expression cells; human C 5 -epimerase (NCBI: NM_015554.1), mouse 6 O ST isoform 1 (NCBI: NM_015818.2), and mouse 6 O ST isoform 3 (NCBI: NM_015820.3) in pMAL-c2x expression vector and Rosetta-gami-B with GroEL expression cells; hamster 2- O ST (GenBank: D88811.1) in pMAL-c2x expression vector and Rosetta-gami-B expression cells; mouse 3 O ST-1 (NCBI: NM_010474.2) in pET28 expression vector and BL21(DE3)RIL expression cells.…”
Section: Methodsmentioning
confidence: 99%